When General Counsel at biotech firm Genelabs Technologies learned that one of the big ten pharmaceutical companies was going to acquire the company it had to act quickly. With IntraLinks already in place to archive critical information the due diligence process began immediately. The companies announced the acquisition just 19 days after signing their exclusivity agreement.

General Counsel for biotech firm Genelabs Technologies maximised the company’s business opportunities with IntraLinks. The on-demand solution, which streamlines critical information exchange internally and externally, improved Genelabs’s staff efficiency by 25%, reduced costs and provided an effective platform for optimising due diligence for licensing and asset sales as well as managing communications with outside financial and legal advisors.

To read the complete case study please click here.